InfuSystem Holdings, Inc
Company Stats
- Market Cap
- $256.7M
- as of Sep 30, 2026
- Enterprise Value
- $273.5M
- Shares Outstanding
- 19.9M
- Free Float
- 70.0%
Income Statement
- Revenue
- $143.4M
- Operating Income
- $11.9M
- Net Income
- $6.6M
- EBITDA
- $24.3M
- Revenue Growth, 3Y
- 9.3%
- FCF Margin, 3Y Avg
- 13.0%
- FCF Margin, Worst Year
- 8.1%
Cash Flow
- Free Cash Flow
- $23.8M
- FCF Yield
- 9.3%
- Owner FCF Yield
- 7.6%
Balance Sheet
- Cash & Equivalents
- $3.2M
- Total Debt
- $20.0M
- Net Debt
- $16.8M
- Net Debt / EBITDA
- 0.69x
- EV / EBITDA
- 11.26x
- Net Debt / EBIT
- 1.41x
Returns & Capital
- Share Repurchases
- $9.9M
- Buyback Yield, 3Y Avg
- 1.5%
- SBC, 3Y Avg
- $4.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $143.4M | $23.8M | 16.6% |
| FY2024 | $134.9M | $19.4M | 14.4% |
| FY2023 | $125.8M | $10.2M | 8.1% |
| FY2022 | $109.9M | $16.5M | 15.0% |
| FY2021 | $102.4M | $17.3M | 16.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 11, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges